Skip to main content

Advertisement

Log in

Validation of the Aldosteronoma Resolution Score as a Predictive Resolution Score of Hypertension After Unilateral Adrenalectomy for Primary Aldosteronism in a North-African Population

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Unilateral primary aldosteronism (UPA) is the most frequent surgically curable form of endocrine hypertension. Adrenalectomy is the cornerstone of treatment for UPA, but outcomes after surgery are variable. Aldosteronoma Resolution Score (ARS) is a four-item predictive score for the cure of hypertension after adrenalectomy for UPA and has been demonstrated to be valid in different populations. We aimed in this study to validate the accuracy of this score in a North-African population.

Methods

Between 2000 and 2021, the charts of 71 Tunisian patients who underwent laparoscopic adrenalectomy for UPA were retrospectively reviewed. Postoperative outcomes were assessed using the primary aldosteronism surgical outcome (PASO) criterion. The accuracy of the ARS was determined retrospectively by receiver operating characteristic curve and area under the curve.

Results

Thirty-four patients (48%) had complete clinical success according to the PASO criteria. Multivariate regression analysis revealed that the main determinants of complete clinical success were the absence of diabetes (OR: 5.205), a BMI <30 (OR: 4.930), a number of antihypertensive medications ≤2 (OR: 8.667), a plasma ARR >332 (OR: 4.554) and an ARS score ≥3 (OR: 2.056). Cure rates were, respectively, 21.1, 51.6, and 66.6% for patients with a score ARS 0–1, 2–3, and 4–5. The AUC of the ARS was 0.837.

Conclusion

The ARS is a sufficiently predictive score in our North-African population. It may be used preoperatively to predict the outcome after adrenalectomy in these populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Conn JW (1955) Primary aldosteronism. J Lab Clin Med 45:661–664

    CAS  PubMed  Google Scholar 

  2. Douma S, Petidis K, Doumas M et al (2008) Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371:1921–1926

    Article  CAS  PubMed  Google Scholar 

  3. Hannemann A, Wallaschofski H (2012) Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies-a review of the current literature. Horm Metab Res 44:157–162

    Article  CAS  PubMed  Google Scholar 

  4. Rossi GP, Bernini G, Caliumi C et al (2006) A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 48:2293–2300

    Article  CAS  PubMed  Google Scholar 

  5. Savard S, Amar L, Plouin PF et al (2013) Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62:331–336

    Article  CAS  PubMed  Google Scholar 

  6. Catena C (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 14(168):80

    Article  Google Scholar 

  7. Rossi GP, Bernini G, Desideri G et al (2006) Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48:232–238

    Article  CAS  PubMed  Google Scholar 

  8. Stowasser M (2001) New perspectives on the role of aldosterone excess in cardiovascular disease. Clin Exp Pharmacol Physiol 28:783–791

    Article  CAS  PubMed  Google Scholar 

  9. Funder JW, et al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:1889–916

  10. Benham JL, Eldoma M, Khokhar B et al (2016) Proportion of patients with hypertension resolution following adrenalectomy for primary aldosteronism: a systematic review and meta-analysis. J Clin Hypertens 18:1205–1212

    Article  Google Scholar 

  11. Steichen O, Zinzindohoué F, Plouin PF et al (2012) Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res 44:221–227

    Article  CAS  PubMed  Google Scholar 

  12. Williams TA, Lenders JWM, Mulatero P et al (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5(9):689–699

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zarnegar R, Young WF, Lee J et al (2008) The Aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247(3):511–518

    Article  PubMed  Google Scholar 

  14. Utsumi T, Kawamura K, Imamoto T et al (2012) High predictive accuracy of aldosteronoma resolution score in Japanese patients with aldosterone-producing adenoma. Surgery 151(3):437–443

    Article  PubMed  Google Scholar 

  15. Pasquier L, Kirouani M, Fanget F et al (2017) Assessment of the aldosteronoma resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients. Langenbecks Arch Surg 402(2):309–314

    Article  PubMed  Google Scholar 

  16. International CONNsortium Study Group et al. (2019) Validation of the Aldosteronoma resolution score within current clinical practice. World J Surg 43(10):2459–2468

  17. Nejjari C, Arharbi M, Chentir MT et al (2013) Epidemiological Trial of Hypertension in North Africa (ETHNA): an international multicentre study in Algeria, Morocco and Tunisia. J Hypertens 31:49–62

    Article  CAS  PubMed  Google Scholar 

  18. Boujnah R, Nazek L, Maalej M et al (2018) Hypertension in Tunisian adults attending primary care physicians (ETHNA-Tunisia). Indian Heart J 70:544–547

    Article  PubMed  Google Scholar 

  19. Sywak M, Pasieka JL (2002) Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 89:1587–1593

    Article  CAS  PubMed  Google Scholar 

  20. Stowasser M, Gordon RD (2016) Primary Aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney. Physiol Rev 96:1327–1384

    Article  CAS  PubMed  Google Scholar 

  21. Romero-Velez G, Laird AM, Barajas ME et al (2021) Outcomes of Adrenalectomy and the Aldosteronoma resolution score in the black and hispanic population. World J Surg 45:1475–1482

    Article  PubMed  PubMed Central  Google Scholar 

  22. Burrello J, Burrello A, Stowasser M et al (2020) The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary Aldosteronism. Ann Surg 272:1125–1132

    Article  PubMed  Google Scholar 

  23. O’Toole SM, Hornby C, Sze WC et al (2021) Performance evaluation of scoring systems for predicting postoperative hypertension cure in primary aldosteronism. Clin Endocrinol (Oxford) 95:576–586

    Article  Google Scholar 

  24. Kempers MJE (2009) Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary Aldosteronism. Ann Intern Med 151:329–337

    Article  PubMed  Google Scholar 

  25. Zarnegar R, Bloom AI, Lee J et al (2008) is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy? J Vasc Interv Radiol 19:66–71

    Article  PubMed  Google Scholar 

  26. Dekkers T, Prejbisz A, Kool LJS et al (2016) Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomized diagnostic trial. Lancet Diabetes Endocrinol 4:739–746

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to all the Urology and Endocrinology Department staff of Charles Nicolle Hospital who contributed to this project.

Funding

No financial funding was used in this work.

Author information

Authors and Affiliations

Authors

Contributions

Study conception and Design: Ahmed Saadi, Mohamed Ali Bedoui, and Ibtissem Ben Nacef. Acquisition of data: Ahmed Saadi, Mohamed Ali Bedoui, Selim Zaghbib, Ibtissem Ben Nacef, Hamza Boussaffa, and Seif Mokadem. Analysis and interpretation of data: Ahmed Saadi, Mohamed Ali Bedoui, Selim Zaghbib, and Ibtissem Ben Nacef. Drafting of the manuscript: Ahmed Saadi and Mohamed Ali Bedoui. Critical revision of the manuscript: Ahmed Saadi, Ibtissem Ben Nacef, Abderrazek Bouzouita, Amine Derouiche, Karima Khiari Marouene Chakroun, and Riadh Ben Slama. Administrative support: Haroun Ayed, Abderrazek Bouzouita, Amine Derouiche, Karima Khiari, Marouene Chakroun, and Riadh Ben Slama. Final approval of manuscript: All Authors.

Corresponding author

Correspondence to Mohamed Ali Bedoui.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Ethical approval

Ethical approval is not required for this study in accordance with local and national guidelines. Written informed consent was obtained from the patient for publication of the details of their medical case.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saadi, A., Bedoui, M.A., Zaghbib, S. et al. Validation of the Aldosteronoma Resolution Score as a Predictive Resolution Score of Hypertension After Unilateral Adrenalectomy for Primary Aldosteronism in a North-African Population. World J Surg 47, 2776–2783 (2023). https://doi.org/10.1007/s00268-023-07155-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-023-07155-6

Navigation